US 8003103
High affinity human antibodies to human IL-18 receptor
granted A61PA61P1/00A61P19/02
Quick answer
US patent 8003103 (High affinity human antibodies to human IL-18 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/00, A61P19/02, A61P25/00, A61P29/00